Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001140361-25-000626
Filing Date
2025-01-08
Accepted
2025-01-08 16:30:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 ny20041059x1_424b3.htm 424B3 174249
2 logo_cartesian.jpg GRAPHIC 42894
3 logo_cartesianx1.jpg GRAPHIC 58064
  Complete submission text file 0001140361-25-000626.txt   314052
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-283803 | Film No.: 25518875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)